ALPS Medical Breakthroughs ETF

SBIO

Market cap $84.1M

Overview Fund Activity

36.19 USD

-0.62

1.68%

At close Updated Sep 12, 4:00 PM EDT

1 day

-1.68%

5 days

-2.51%

1 month

7.48%

3 months

15.7%

6 months

16.86%

Year to date

8.58%

1 year

-1.66%

5 years

-11.26%

10 years

4.41%

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

5.91% more ownership

Funds ownership: 98.45% [Q1] → 104.36% (+5.91%) [Q2]

6% more funds holding

Funds holding: 34 [Q1] → 36 (+2) [Q2]

2% more capital invested

Capital invested by funds: $73M [Q1] → $74.3M (+$1.34M) [Q2]

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

See Fund Rankings

Financial journalist opinion

Based on 3 articles about SBIO published over the past 30 days

3 Stocks Driving Biotech ETF SBIO's Appeal

In the shifting landscape of ETFs, many funds claim to offer exposure to innovation. Technology plays a key role as a growth industry and a driver for performance across the economy overall, as well.

3 Stocks Driving Biotech ETF SBIO's Appeal

This Underrated Tech ETF Is Spiking Amid Rate Cut Hype

Looking to add some diversification and upside to your equities allocation? While the broader tech space has largely relied on just a handful of names, smaller subcategories in innovative tech also have a role to play.

This Underrated Tech ETF Is Spiking Amid Rate Cut Hype

Is Biotech the Right Tech ETF Move Right Now? SBIO Argues Yes

The tech ETF space offers plenty of important questions for investors.

Is Biotech the Right Tech ETF Move Right Now? SBIO Argues Yes

Small-Cap Biotech Stocks Ready to Shine

Biotech stocks and related ETFs are in the midst of a lengthy period of underperformance. For the three years ending July 9, the largest ETF in the category returned just 11%.

Small-Cap Biotech Stocks Ready to Shine

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Healthcare Innovation Alive & Well in SBIO

It's understandable investors are frustrated with broader measures of small-cap equities. They've been hearing about the possibility of smaller stocks outperforming larger counterparts for a while.

Healthcare Innovation Alive & Well in SBIO

This Tech Sector ETF Could Zig Where Others Zag

With tech earnings arriving, many investors are still likely fearing a downturn for key information technology stocks. The so-called Magnificent Seven stocks delivered significant performance for investors last year.

This Tech Sector ETF Could Zig Where Others Zag

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Healthcare Stocks Could Merit Prescriptions in 2025

It's been a long road of disappointment for healthcare stocks. And biotechnology names have been among the worst offenders.

Healthcare Stocks Could Merit Prescriptions in 2025

SBIO ETF: Betting On Medical Breakthroughs

ALPS Medical Breakthroughs ETF is rated Hold due to high fees, low yield, and mixed performance compared to other healthcare ETFs. The SBIO ETF focuses on small and mid-cap biotech companies with drugs in Phase II or III FDA trials, offering targeted exposure to medical breakthroughs. Despite an aging population driving healthcare demand, sector headwinds and government budget pressures make healthcare stocks less attractive for generating Alpha.

SBIO ETF: Betting On Medical Breakthroughs

See News Rankings

Charts implemented using Lightweight Charts™